Ester Falconer serves as Executive at AbCellera Biologics Inc., where they oversee executive responsibilities. Since joining the company, Ester Falconer has executed 3 insider transactions totaling $25.5M, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 1, 2021 involved exercising options for 875,000 shares valued at $14.8M.
Ester Falconer currently holds 875,000 shares of AbCellera Biologics Inc. (ABCL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ester Falconer has been a net seller of ABCL stock. They have purchased $0 and sold $25.5M worth of shares.
Ester Falconer's most recent insider trade was on Sep 1, 2021, when they sold 875,000 shares at $16.89 per share.
Get notified when new Form 4 filings are submitted
| $25.50 |
| Discretionary |
| Mar 19, 2021 | ABCL | $30.0K | Option Exercise | 1,000,000 | $0.03 | Discretionary |